We are live on ! Find out more
ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $3.76B
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
+7.17%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+474.07%
AUM
$8.8B
AUM Growth
+$725M
Cap. Flow
+$260M
Cap. Flow %
2.95%
Top 10 Hldgs %
18.97%
Holding
350
New
35
Increased
118
Reduced
110
Closed
19

Sector Composition

Rank Sector Weight
1 Industrials 28.2%
2 Technology 19.49%
3 Healthcare 15.43%
4 Consumer Discretionary 13.4%
5 Financials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JUNO
51
DELISTED
Juno Therapeutics, Inc.
JUNO
$58.9M 0.67%
1,313,932
-308,448
-19% -$10.5M
RVNC
52
DELISTED
Revance Therapeutics, Inc.
RVNC
$58.8M 0.67%
2,135,521
+89,659
+4% +$2.17M
PBH icon
53
Prestige Consumer Healthcare
PBH
$2.46B
$58.8M 0.67%
1,173,878
+236,014
+25% +$12.1M
CASY icon
54
Casey's General Stores
CASY
$31.8B
$56.1M 0.64%
512,519
+24,995
+5% +$2.66M
COO icon
55
Cooper Companies
COO
$14.5B
$55.9M 0.64%
943,072
-5,396
-0.6% -$330K
NBIX icon
56
Neurocrine Biosciences
NBIX
$16.7B
$54.4M 0.62%
887,946
-7,633
-0.9% -$403K
MIDD icon
57
Middleby
MIDD
$6.14B
$52.9M 0.6%
+412,912
New +$50.9M
MDSO
58
DELISTED
Medidata Solutions, Inc.
MDSO
$52.4M 0.6%
671,181
-218,846
-25% -$16.7M
EVH icon
59
Evolent Health
EVH
$353M
$51.3M 0.58%
2,882,450
+1,397,580
+94% +$28.8M
BLUE
60
DELISTED
bluebird bio
BLUE
$49.7M 0.56%
27,933
-5,299
-16% -$7.4M
IMMU
61
DELISTED
Immunomedics Inc
IMMU
$49.2M 0.56%
3,519,500
+2,096,383
+147% +$20.9M
ATHN
62
DELISTED
Athenahealth, Inc.
ATHN
$48.9M 0.56%
393,452
-124,679
-24% -$17.2M
CYBR
63
DELISTED
CyberArk
CYBR
$48.2M 0.55%
+1,176,463
New +$49.8M
ECOM
64
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$47.1M 0.53%
4,092,319
+16,767
+0.4% +$182K
RNET
65
DELISTED
RigNet, Inc.
RNET
$46M 0.52%
2,674,184
-11,503
-0.4% -$196K
ATRA icon
66
Atara Biotherapeutics
ATRA
$77M
$45.9M 0.52%
111,029
+27,708
+33% +$10.4M
HQY icon
67
HealthEquity
HQY
$8.72B
$45.9M 0.52%
907,342
+89,425
+11% +$4.16M
EXA
68
DELISTED
EXA Corporation
EXA
$45M 0.51%
1,860,396
+363,267
+24% +$5.3M
EEFT icon
69
Euronet Worldwide
EEFT
$2.8B
$45M 0.51%
474,378
+12,343
+3% +$1.17M
MMS icon
70
Maximus
MMS
$3.27B
$44.7M 0.51%
693,606
-354,302
-34% -$21.7M
DBVT
71
DBV Technologies
DBVT
$804M
$43.7M 0.5%
103,019
+4,407
+4% +$1.89M
HCCI
72
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$43.6M 0.5%
2,004,534
-172,167
-8% -$3.21M
ABCO
73
DELISTED
Advisory Board Co
ABCO
$43.2M 0.49%
805,243
+26,008
+3% +$1.4M
DXCM icon
74
DexCom
DXCM
$32.9B
$42.7M 0.49%
3,493,012
+990,216
+40% +$17.5M
SP
75
DELISTED
SP Plus Corporation
SP
$42.6M 0.48%
1,078,135
-45,013
-4% -$1.58M

Similar funds

ArrowMark Colorado Holdings's Q3 2017 Portfolio in Review

As of Q3 2017, ArrowMark Colorado Holdings held 350 positions worth $8.8B, up 9% from $8.08B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

ArrowMark Colorado Holdings's Q3 2017 filing shows 35 new, 118 increased, 110 reduced and 19 closed positions. Its largest new stake was Middleby: 412,912 shares worth $52.9M. The largest sale was Spectranetics Corp, an estimated $95.5M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

  • ArrowMark Colorado Holdings's largest Q3 2017 buy was Middleby: 412,912 shares worth $52.9M.
  • ArrowMark Colorado Holdings added most to MSC Industrial Direct in Q3 2017, an estimated $66M increase.
  • ArrowMark Colorado Holdings's biggest Q3 2017 reduction was 2U Inc, cutting an estimated $54.3M.
  • ArrowMark Colorado Holdings fully exited Spectranetics Corp in Q3 2017, selling an estimated $95.5M.
  • ArrowMark Colorado Holdings's ten largest holdings make up 19% of its $8.8B portfolio in Q3 2017.
  • ArrowMark Colorado Holdings opened 35 new positions and closed 19 in Q3 2017.
  • ArrowMark Colorado Holdings's portfolio value rose 9% quarter-over-quarter to $8.8B.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2017, filed 14 Nov 2017.